Ignite Creation Date:
2025-12-24 @ 2:28 PM
Ignite Modification Date:
2026-01-06 @ 5:09 AM
Study NCT ID:
NCT01712659
Status:
TERMINATED
Last Update Posted:
2023-01-10
First Post:
2012-10-20
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Ruxolitinib for Adult T-Cell Leukemia
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-10-26
Start Date Type:
ACTUAL
Primary Completion Date:
2021-11-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-01-18
Completion Date Type:
ACTUAL
First Submit Date:
2012-10-20
First Submit QC Date:
None
Study First Post Date:
2012-10-23
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2022-11-10
Results First Submit QC Date:
None
Results First Post Date:
2023-01-10
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-12-15
Last Update Post Date:
2023-01-10
Last Update Post Date Type:
ACTUAL